Ergoteles’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-79,770	Closed	-$250K	–	1088
2023 Q1	$250K	Buy	+79,770	New	+$250K	0.01%	947
2022 Q3	–	Sell	-43,500	Closed	-$328K	–	1584
2022 Q2	$328K	Buy	+43,500	New	+$328K	0.01%	1059